• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Physico-chemical determinants of soluble intrabody expression in mammalian cell cytoplasm.哺乳动物细胞质中可溶内体表达的理化决定因素。
Protein Eng Des Sel. 2010 Jun;23(6):489-98. doi: 10.1093/protein/gzq022. Epub 2010 Apr 8.
2
Fusion to a highly charged proteasomal retargeting sequence increases soluble cytoplasmic expression and efficacy of diverse anti-synuclein intrabodies.融合到一个带高电荷的蛋白酶体靶向序列中,可增加不同抗突触核蛋白内抗体在细胞质中的可溶性表达和功效。
MAbs. 2012 Nov-Dec;4(6):686-93. doi: 10.4161/mabs.21696. Epub 2012 Aug 28.
3
Selection for intrabody solubility in mammalian cells using GFP fusions.利用 GFP 融合体在哺乳动物细胞中选择胞内体可溶性蛋白。
Protein Eng Des Sel. 2011 Dec;24(12):873-81. doi: 10.1093/protein/gzr049. Epub 2011 Oct 13.
4
Solubility Characterization and Imaging of Intrabodies Using GFP-Fusions.使用绿色荧光蛋白融合体对胞内抗体进行溶解性表征与成像
Methods Mol Biol. 2017;1575:165-174. doi: 10.1007/978-1-4939-6857-2_9.
5
Differential nuclear localization of complexes may underlie in vivo intrabody efficacy in Huntington's disease.复合物的差异性核定位可能是亨廷顿舞蹈病体内抗体药物疗效的基础。
Protein Eng Des Sel. 2014 Oct;27(10):359-63. doi: 10.1093/protein/gzu041.
6
A combined strategy improves the solubility of aggregation-prone single-chain variable fragment antibodies.一种联合策略可提高易于聚集的单链可变片段抗体的溶解度。
Protein Expr Purif. 2012 May;83(1):21-9. doi: 10.1016/j.pep.2012.02.006. Epub 2012 Feb 23.
7
Making cell-permeable antibodies (Transbody) through fusion of protein transduction domains (PTD) with single chain variable fragment (scFv) antibodies: potential advantages over antibodies expressed within the intracellular environment (Intrabody).通过将蛋白质转导结构域(PTD)与单链可变片段(scFv)抗体融合来制备细胞渗透性抗体(穿膜抗体):相较于细胞内表达的抗体(胞内抗体)的潜在优势。
Med Hypotheses. 2005;64(6):1105-8. doi: 10.1016/j.mehy.2005.01.011.
8
Conformational targeting of fibrillar polyglutamine proteins in live cells escalates aggregation and cytotoxicity.活细胞中纤维状聚谷氨酰胺蛋白的构象靶向会加剧聚集和细胞毒性。
PLoS One. 2009 May 28;4(5):e5727. doi: 10.1371/journal.pone.0005727.
9
Intrabody-mediated diverting of HP1β to the cytoplasm induces co-aggregation of H3-H4 histones and lamin-B receptor.体内介导的HP1β向细胞质的转移诱导H3-H4组蛋白和核纤层蛋白B受体的共聚集。
Exp Cell Res. 2015 Oct 15;338(1):70-81. doi: 10.1016/j.yexcr.2015.09.006. Epub 2015 Sep 10.
10
Intrabody construction and expression. II. A synthetic catalytic Fv fragment.体内构建与表达。二、合成催化性Fv片段。
J Mol Biol. 1999 Sep 3;291(5):1129-34. doi: 10.1006/jmbi.1999.3020.

引用本文的文献

1
A simeprevir-inducible molecular switch for the control of cell and gene therapies.一种可诱导西美瑞韦的分子开关,用于控制细胞和基因治疗。
Nat Commun. 2023 Nov 27;14(1):7753. doi: 10.1038/s41467-023-43484-9.
2
Tau, an sensor of tau multimerization, identifies neuroprotective interventions in tauopathy.Tau,一种 tau 多聚体形成的传感器,可鉴定出 tau 病中的神经保护干预措施。
Cell Rep Methods. 2022 Sep 9;2(9):100292. doi: 10.1016/j.crmeth.2022.100292. eCollection 2022 Sep 19.
3
A Small Virus to Deliver Small Antibodies: New Targeted Therapies Based on AAV Delivery of Nanobodies.一种用于递送小型抗体的病毒:基于腺相关病毒递送纳米抗体的新型靶向疗法。
Microorganisms. 2021 Sep 15;9(9):1956. doi: 10.3390/microorganisms9091956.
4
Nanobodies Right in the Middle: Intrabodies as Toolbox to Visualize and Modulate Antigens in the Living Cell.纳米抗体正当时:胞内抗体作为工具箱,用于在活细胞中可视化和调节抗原。
Biomolecules. 2020 Dec 21;10(12):1701. doi: 10.3390/biom10121701.
5
Engineered Extracellular Vesicles/Exosomes as a New Tool against Neurodegenerative Diseases.工程化细胞外囊泡/外泌体作为对抗神经退行性疾病的新工具。
Pharmaceutics. 2020 Jun 9;12(6):529. doi: 10.3390/pharmaceutics12060529.
6
Applying Antibodies Inside Cells: Principles and Recent Advances in Neurobiology, Virology and Oncology.细胞内抗体应用:神经生物学、病毒学和肿瘤学的原理和最新进展。
BioDrugs. 2020 Aug;34(4):435-462. doi: 10.1007/s40259-020-00419-w.
7
Computational affinity maturation of camelid single-domain intrabodies against the nonamyloid component of alpha-synuclein.驼科单域内抗体针对α-突触核蛋白非淀粉样成分的计算亲和力成熟。
Sci Rep. 2018 Dec 4;8(1):17611. doi: 10.1038/s41598-018-35464-7.
8
A comprehensive in silico characterization of bacterial signal peptides for the excretory production of phenylalanine ammonia lyase in .用于在……中排泄生产苯丙氨酸解氨酶的细菌信号肽的全面计算机模拟表征
3 Biotech. 2018 Dec;8(12):488. doi: 10.1007/s13205-018-1517-3. Epub 2018 Nov 16.
9
Targeted Intracellular Delivery of Antibodies: The State of the Art.抗体的靶向细胞内递送:现状
Front Pharmacol. 2018 Oct 24;9:1208. doi: 10.3389/fphar.2018.01208. eCollection 2018.
10
Exploiting Phage Display for Development of Novel Cellular Targeting Strategies.利用噬菌体展示技术开发新型细胞靶向策略。
Methods Mol Biol. 2018;1831:71-94. doi: 10.1007/978-1-4939-8661-3_7.

本文引用的文献

1
Intrabody gene therapy ameliorates motor, cognitive, and neuropathological symptoms in multiple mouse models of Huntington's disease.体内基因疗法可改善亨廷顿舞蹈病多种小鼠模型的运动、认知和神经病理学症状。
J Neurosci. 2009 Oct 28;29(43):13589-602. doi: 10.1523/JNEUROSCI.4286-09.2009.
2
Developing intrabodies for the therapeutic suppression of neurodegenerative pathology.开发用于治疗性抑制神经退行性病变的胞内抗体。
Expert Opin Biol Ther. 2009 Sep;9(9):1189-97. doi: 10.1517/14712590903176387.
3
Conformational targeting of fibrillar polyglutamine proteins in live cells escalates aggregation and cytotoxicity.活细胞中纤维状聚谷氨酰胺蛋白的构象靶向会加剧聚集和细胞毒性。
PLoS One. 2009 May 28;4(5):e5727. doi: 10.1371/journal.pone.0005727.
4
Selection of non-aggregating VH binders from synthetic VH phage-display libraries.从合成的VH噬菌体展示文库中筛选非聚集性VH结合物。
Methods Mol Biol. 2009;525:187-216, xiii. doi: 10.1007/978-1-59745-554-1_10.
5
The influence of the framework core residues on the biophysical properties of immunoglobulin heavy chain variable domains.框架核心残基对免疫球蛋白重链可变区生物物理特性的影响。
Protein Eng Des Sel. 2009 Mar;22(3):121-34. doi: 10.1093/protein/gzn077. Epub 2009 Jan 10.
6
Characterizing antibody specificity to different protein morphologies by AFM.通过原子力显微镜表征抗体对不同蛋白质形态的特异性。
Langmuir. 2009 Jan 20;25(2):912-8. doi: 10.1021/la8025914.
7
Aggregation-resistant VHs selected by in vitro evolution tend to have disulfide-bonded loops and acidic isoelectric points.通过体外进化筛选出的抗聚集可变重链往往具有二硫键连接的环和酸性等电点。
Protein Eng Des Sel. 2009 Feb;22(2):59-66. doi: 10.1093/protein/gzn071. Epub 2008 Nov 24.
8
Efficient isolation of soluble intracellular single-chain antibodies using the twin-arginine translocation machinery.利用双精氨酸转运机制高效分离可溶性细胞内单链抗体。
J Mol Biol. 2009 Jan 9;385(1):299-311. doi: 10.1016/j.jmb.2008.10.051. Epub 2008 Nov 1.
9
Sequence determinants of protein aggregation in human VH domains.人VH结构域中蛋白质聚集的序列决定因素。
Protein Eng Des Sel. 2009 Mar;22(3):217-20. doi: 10.1093/protein/gzn059. Epub 2008 Oct 28.
10
Intrabodies binding the proline-rich domains of mutant huntingtin increase its turnover and reduce neurotoxicity.与突变型亨廷顿蛋白富含脯氨酸结构域结合的胞内抗体可提高其周转率并降低神经毒性。
J Neurosci. 2008 Sep 3;28(36):9013-20. doi: 10.1523/JNEUROSCI.2747-08.2008.

哺乳动物细胞质中可溶内体表达的理化决定因素。

Physico-chemical determinants of soluble intrabody expression in mammalian cell cytoplasm.

机构信息

New York State Department of Health, Wadsworth Center/ David Axelrod Institute, 120 New Scotland Ave., PO Box 22002, Albany, NY 12201-2002, USA.

出版信息

Protein Eng Des Sel. 2010 Jun;23(6):489-98. doi: 10.1093/protein/gzq022. Epub 2010 Apr 8.

DOI:10.1093/protein/gzq022
PMID:20378699
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2865363/
Abstract

Soluble antibody fragments are desirable not only as potential therapeutic and diagnostic agents for extracellular targets but also as 'intrabodies' for functional genomics, proteomics and gene therapy inside cells. However, antibody fragments are notoriously aggregation-prone when expressed intracellularly, due in part to unfavorable redox potential and macromolecular crowding in cell cytoplasm. Only a small proportion of intrabodies are soluble in cytoplasm and little is known about the sequence determinants that confer such stability. By comparing the cytoplasmic expression of several related human single-chain variable fragments and camelid V(HH)s in mammalian cells, we report that intrabody solubility is highly influenced by CDR content and is improved by an overall negative charge at cytoplasmic pH and reduced hydrophilicity. We hypothesize that ionic repulsion and weak hydrophobic interactions compensate, to different extents, for impaired disulfide bond formation in cytoplasm, thereby decreasing the risk for intrabody aggregation. As proof of principle, we demonstrate that the soluble expression of an aggregation-prone positively charged intrabody is modestly enhanced via cis or trans acidification using highly charged peptide tags (3XFLAG tag, SV40 NLS). These findings suggest that simple sequence analysis and electrostatic manipulation may aid in predicting and engineering solubility-enhanced intrabodies from antibody libraries for intracellular use.

摘要

可溶性抗体片段不仅是针对细胞外靶标的潜在治疗和诊断剂,也是细胞内功能基因组学、蛋白质组学和基因治疗的“内抗体”。然而,抗体片段在细胞内表达时极易聚集,部分原因是细胞细胞质中还原电势和大分子拥挤不利。只有一小部分内抗体在细胞质中是可溶的,并且对于赋予这种稳定性的序列决定因素知之甚少。通过比较几种相关的人类单链可变片段和骆驼科 V(HH)s 在哺乳动物细胞中的细胞质表达,我们报告说内抗体的可溶性受 CDR 含量的高度影响,并受细胞质 pH 值下的总体负电荷和降低的亲水性影响。我们假设离子排斥和弱疏水相互作用在不同程度上补偿了细胞内二硫键形成的受损,从而降低了内抗体聚集的风险。作为原理证明,我们通过使用高电荷肽标签(3XFLAG 标签、SV40 NLS)进行顺式或反式酸化,证明了一种易于聚集的带正电荷的内抗体的可溶性表达适度增强。这些发现表明,简单的序列分析和静电处理可以帮助预测和设计用于细胞内使用的抗体文库中的可溶性增强内抗体。